Cellebrite DI Ltd. awarded director Richardson Troy 15,190 shares at $0 on 2026-09-17, leaving him with 36,164 shares. For investors, the stated 42.0% figure shows the award’s size relative to Troy’s resulting ownership in Cellebrite DI Ltd., without changing the disclosed per-share price.
Key Highlights
- Richardson Troy received 15,190 Cellebrite DI Ltd. shares at $0 per share.
- The award was recorded on 17 September 2026 under transaction code A.
- Troy’s resulting ownership stood at 36,164 shares, with the award representing about 42.0% of that total.
Cellebrite DI Ltd. (NASDAQ: CLBT) is a packaged software company. Director Richardson Troy received 15,190 shares at $0 per share, with the award recorded on 17 September 2026. His resulting ownership was 36,164 shares.
Share Award Recorded at Zero Cost
The transaction covers Cellebrite DI Ltd. shares awarded to Troy at no cost per share.
Award Represents 42.0% of Resulting Holding
The 15,190-share award represented about 42.0% of Troy’s resulting shares holding. That comparison places the transaction against the ownership figure reported after the award. Cellebrite DI Ltd. reported the per-share value as $0.
FAQs
Q: How many shares did Richardson Troy receive from Cellebrite DI Ltd.?
A: Richardson Troy received 15,190 Cellebrite DI Ltd. shares. The shares were awarded at $0 per share in the transaction recorded on 17 September 2026.
Q: What was the price of Richardson Troy’s Cellebrite share award?
A: The Cellebrite DI Ltd. share award was recorded at $0 per share. The transaction involved 15,190 shares awarded to Richardson Troy.
Q: How many Cellebrite DI Ltd. shares did Troy own after the award?
A: Richardson Troy’s resulting Cellebrite DI Ltd. holding was 36,164 shares. The award represented about 42.0% of that resulting shareholding.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.